Geode Capital Management LLC Boosts Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Geode Capital Management LLC grew its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 6.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,523,408 shares of the company’s stock after purchasing an additional 87,671 shares during […]

Related Keywords

Raymond James ,Neurocrine Biosciences ,Julie Cooke ,Garya Lyons ,Kb Financial Partners ,Nasdaq ,Bessemer Group Inc ,Neurocrine Biosciences Inc ,Geode Capital Management ,Exchange Commission ,Cantor Fitzgerald ,Securities Exchange Commission ,Neurocrine Biosciences Company Profile ,Covestor Ltd ,Acadian Asset Management ,Free Report ,Capital Management ,Asset Management ,Spire Wealth Management ,Wealth Management ,Director Gary ,Get Free Report ,Visit Holdingschannel ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,